Enze Liu

6PUBLICATIONS
31CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
SGLT-2 Inhibitors are Associated With a Lower Risk of Multiple Myeloma.

|Jul 28, 2026
Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and Resistance.

|Oct 15, 2025
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection.

Parvathi Sudha, Phillip Pham, Wen Niu

|May 08, 2025
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.

Parvathi Sudha, Travis S Johnson, Habib Hamidi

|Oct 14, 2022
Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer.

Yang Huo, Shuai Shao, Enze Liu

|Aug 19, 2022
DSCN: Double-target selection guided by CRISPR screening and network.

Enze Liu, Xue Wu, Lei Wang

Pageof 1

Frequent Collaborators

4 joint publications

Brian A Walker

3 joint publications

Attaya Suvannasankha

2 joint publications

Parvathi Sudha

2 joint publications

Travis S Johnson